Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Parren

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Virology|November 13, 1998
Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1P W Parren, M Wang, A Trkola, et al.
Journal of Molecular Biology|April 4, 1997
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display librariesH J Ditzel, P W Parren, J M Binley, et al.
AIDS (London, England)|July 14, 2000
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the GambiaL Dorrell, A J Hessell, M Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3P W Parren, P A Warmerdam, L C Boeije, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
The Journal of Infectious Diseases|February 13, 1999
Recombinant human monoclonal antibodies to Ebola virusT Maruyama, P W Parren, A Sanchez, et al.
Journal of Virology|January 7, 1998
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaqueJ Glamann, D R Burton, P W Parren, et al.
Journal of Virology|August 3, 2001
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroP W Parren, P A Marx, A J Hessell, et al.
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
International Immunology|March 1, 1993
Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclassesP A Warmerdam, I E van den Herik-Oudijk, P W Parren, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Virology|November 13, 1998
Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1P W Parren, M Wang, A Trkola, et al.
Journal of Molecular Biology|April 4, 1997
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display librariesH J Ditzel, P W Parren, J M Binley, et al.
AIDS (London, England)|July 14, 2000
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the GambiaL Dorrell, A J Hessell, M Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3P W Parren, P A Warmerdam, L C Boeije, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
The Journal of Infectious Diseases|February 13, 1999
Recombinant human monoclonal antibodies to Ebola virusT Maruyama, P W Parren, A Sanchez, et al.
Journal of Virology|January 7, 1998
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaqueJ Glamann, D R Burton, P W Parren, et al.
Journal of Virology|August 3, 2001
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroP W Parren, P A Marx, A J Hessell, et al.
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
International Immunology|March 1, 1993
Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclassesP A Warmerdam, I E van den Herik-Oudijk, P W Parren, et al.
Pageof 6